EXOZ logo

eXoZymes, Inc. Stock Price

NasdaqCM:EXOZ Community·US$104.6m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

EXOZ Share Price Performance

US$0
-20.52 (-100.00%)
US$0
-20.52 (-100.00%)
Price US$0

EXOZ Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Adequate balance sheet with slight risk.

4 Risks
0 Rewards

eXoZymes, Inc. Key Details

US$0

Revenue

US$0

Cost of Revenue

US$0

Gross Profit

US$8.3m

Other Expenses

-US$8.3m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
-0.99
0%
0%
0%
View Full Analysis

About EXOZ

Founded
2014
Employees
31
CEO
Michael Heltzen
WebsiteView website
www.exozymes.com

eXoZymes, Inc. operates as a development stage biotechnology company. The company focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.

Recent EXOZ News & Updates

Recent updates

No updates